Lyxor tracks rising euphoria in Chinese equity markets

Lyxor Asset Management in its weekly briefing pointed out the recent surge in Chinese equity indices of 15% in July. They said the rally is unfolding in extreme trading volumes that is fed by strong domestic and foreign capital inflows. In part officials say that China’s restarting of its economy has positively surprised investors as the resurgence of coronavirus infection cases has proven to be manageable so far. “Equity markets are also benefiting from strong macro liquidity, a large part of which resulted from Chinese authorities’ targeted but continued stimulus,” wrote Lyxor’s research team. They also say that the lag in Chinese equity valuation relative to other foreign markets has not reflected China’s relative success in managing the virus impact. There are market risks, however, as the stock indices reach their 2017 pre-trade-war resistance levels and the trade ramifications following the removal of Hong Kong from preferential trade status with the U.S. and expected U.S. tariff escalation. So far though, Chinese Equity UCITS funds tracked by Lyxor had successfully captured the stock rally. These funds have increased their net exposure over the recent months to record levels and have benefited from their tilt towards growth, quality, technology and tertiary/services stocks, as well as those likely to benefit from infrastructure spending. Lyxor estimates that the active Chinese equity strategies are generating alpha and have fully recovered losses from earlier this year.

Lyxor tracks rising euphoria in Chinese equity markets

Continue Reading With a Free Trial

Sphera Healthcare makes key U.S. hires

Former Bessemer CIO joins Bridgewater

Welcome to Alternatives Watch

Finding the single source of truth in private equity data

Buck hires former AndCo exec for manager research

Hybrid VC Firm rolls out second cannabis fund

Compliance chiefs eye insider trading risks in the new WFH era

Ares closes on $4.4bn in direct lending in H1 2020

Florida pension completes $3bn in alts allocations in Q2

Sphera Healthcare makes key U.S. hires

HITE refuels its energy sector focus with one key short

Continue Reading With a Free Trial

Be an Alts Watcher

Subscribe to our mailing list and know first!

J.P. Morgan taps PIMCO exec as head of institutional portfolio strategy

Bridge closes opportunity zones strategy with $1.3bn

Related Articles

Get our daily news digest in your inbox

Get our daily news digest
in your inbox